Stocks · Health care · Pharmaceutical Preparations

Annexon, Inc.

ANNX Clue Score37
United States Fiscal year ends December CIK 0001528115 Results filed 12 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Ted Yednock
11 Jun 2026
EVP & Chief Innovation Officer
Exercised, kept
30,646
$1.85
$56.70K
Douglas Love
6 Jan 2025
President and CEO
Exercised, kept
37,994
$1.41
$53.56K
Douglas Love
30 Oct 2024
President and CEO
Exercised, kept
36,050
$1.85
$66.70K
Douglas Love
30 Oct 2024
President and CEO
Exercised, kept
78,399
$1.85
$145.05K
Douglas Love
11 Nov 2021
President & CEO
Exercised, kept
30,000
$1.85
$55.50K
Douglas Love
11 Nov 2021
President & CEO
Exercised, kept
70,942
$1.41
$100.00K

What was left out

Form 4 filings counted 172
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 25
Sales at will 39
Transactions with no price 0
Shares from compensation/vesting 10,927,333
Sales filed before the plan box existed 5
History held since 24 Jul 2020